FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and medicine and concerns antagonising the hedgehog signalling pathway in a cell by using the methods of treating cancer with a cyclopamide derivative of general formula
(1).
EFFECT: developing the new method of treating cancer.
34 cl, 5 tbl, 35 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CYCLOPAMINE ANALOGUES | 2007 |
|
RU2486194C2 |
| CYCLOPAMINE ANALOGUES AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2403256C2 |
| MAGL INHIBITORS | 2017 |
|
RU2754536C1 |
| PYRIDYL-PIPERIDINE ANTAGONISTS OF OREXIN RECEPTORS | 2008 |
|
RU2470021C2 |
| TRICYCLIC COMPOUNDS PROVIDING DESTRUCTION OF IKAROS PROTEIN AND AIOLOS PROTEIN | 2020 |
|
RU2833608C2 |
| SPIROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND USE | 2018 |
|
RU2781639C2 |
| IMIDAZOPYRROLOPYRINE DERIVATIVES USEFUL FOR TREATING DISEASES CAUSED BY ABNORMAL ACTIVITY OF PROTEIN KINASES JAK1, JAK3 OR SYK | 2010 |
|
RU2711869C2 |
| PRIMARY CARBOXAMIDES AS BTK INHIBITORS | 2014 |
|
RU2708395C2 |
| IAP INHIBITORS | 2005 |
|
RU2401840C2 |
| TRICYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEM AND USING THEM FOR TREATING IMMUNOLOGICAL AND ONCOLOGICAL COMPOUNDS | 2009 |
|
RU2545023C9 |
Authors
Dates
2013-09-20—Published
2007-12-27—Filed